Barriers to recruitment in cancer trials: no longer medical oncologists’ attitudes

• 1 Sydney Medical School, University of Sydney, Sydney, NSW.
• 2 Sydney School of Public Health, University of Sydney, Sydney, NSW.

---

• 1. Fallowfield L, Ratcliffe D, Souhami R. Clinicians’ attitudes to clinical trials of cancer therapy. Eur J Cancer 1997; 33: 2221-2229.
• 2. Taylor KM, Feldstein ML, Skeel RT, et al. Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators. J Clin Oncol 1994; 12: 1796-1805.
• 3. Ginn S. Global clinical trials are burdened by excessive bureaucracy, conference hears. BMJ 2011; 343: d6322.
• 4. Probstfield JL, Frye RL. Strategies for recruitment and retention of participants in clinical trials. JAMA 2011; 306: 1798-1799.
• 5. Clinical Trials Action Group. Clinically competitive: boosting the business of clinical trials in Australia. Canberra: Department of Innovation, Industry, Science and Research, 2011. http://www.innovation.gov.au/Industry/PharmaceuticalsandHealthTechnologies/ClinicalTrialsActionGroup/Documents/Clinical_Trials_Action_Group_Report.pdf (accessed Nov 2011).